Proprotein convertase subtilisin/ kexin type 9 levels and arterial function
Koutagiar, I. +10 more
openaire +2 more sources
Correction: Association of thyroid autoimmunity and pregnancy outcomes in unexplained recurrent pregnancy loss women: a prospective cohort study. [PDF]
Wang R +5 more
europepmc +1 more source
Effectiveness of PCSK9 inhibitors versus statins in type 2 diabetes and dyslipidemia: a propensity-matched study. [PDF]
Wu JY +8 more
europepmc +1 more source
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: comparing and contrasting guidance across the Atlantic [PDF]
Marc S. Sabatine
openalex +1 more source
Natural phytochemicals as small-molecule proprotein convertase subtilisin/kexin type 9 inhibitors
Je-Wen Liou +3 more
openalex +1 more source
Can proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors regress coronary atherosclerotic plaque? A systematic review and meta-analysis. [PDF]
Zijia Wu, Lulan Gao, Zhihai Lin
openalex
Performance evaluation of the ACTIVE 7 MAX benchtop preclinical PET scanner in accordance with the NEMA NU 4-2008 standard. [PDF]
Wang H +10 more
europepmc +1 more source
Multimodal assessment of treatment with proprotein convertase subtilisin/kexin type 9 inhibitors combined with statins for regulating coronary artery plaque regression in patients with chronic/acute coronary syndrome: A meta-analysis. [PDF]
Yuan D, Cheng T, Cao Z, Wang F, Wang Y.
europepmc +1 more source
Familial Hypercholesterolaemia and the Risk of Cardiovascular Events. [PDF]
Conchinha A +4 more
europepmc +1 more source

